J. C. Madelmont

944 citations

53 papers · 800 indexed · h-index 15

Co-authors: Janine Papon Daniel Morvan Aïcha Demidem J. C. Maurizis P. Chollet Eric Cellarier Nicole Moins Marie‐Paule Vasson
Topics: Amino Acid Enzymes and Metabolism (8 papers)Cancer therapeutics and mechanisms (8 papers)Cancer, Hypoxia, and Metabolism (6 papers)
Cited by: Biochemistry Biotechnology Pharmaceutical Science
Journals: Journal of Medicinal Chemistry British Journal of Cancer Journal of Pharmacology and Experimental Therapeutics
Partner nations: France Canada Mali

In The Last Decade

J. C. Madelmont

52 papers receiving 783 citations

Peers

Countries citing papers authored by J. C. Madelmont

Since Specialization

Citations

This map shows the geographic impact of J. C. Madelmont's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. C. Madelmont with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. C. Madelmont more than expected).

Fields of papers citing papers by J. C. Madelmont

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. C. Madelmont. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. C. Madelmont. The network helps show where J. C. Madelmont may publish in the future.

Co-authorship network of co-authors of J. C. Madelmont

This figure shows the co-authorship network connecting the top 25 collaborators of J. C. Madelmont. A scholar is included among the top collaborators of J. C. Madelmont based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. C. Madelmont. J. C. Madelmont is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Melanoma vectorized radiotherapy: preclinical evaluation of a new marker labelled by iodine 131 2010 ·Médecine Nucléaire ·Mathilde Bonnet,Janine Papon,Elisabeth Miot‐Noirault,J. C. Madelmont,Jean‐Michel Chezal,Nicole Moins,Florence Mishellany,(unknown),Anne Cayre	1
2	N-4-iodophenyl-N′-2-chloroethylurea, a novel potential anticancer agent with colon-specific accumulation: radioiodination and comparative in vivo biodistribution profiles 2009 ·Investigational New Drugs ·Emmanuelle Mounetou,Elisabeth Miot-Noirault,René C.‐Gaudreault,J. C. Madelmont	8
3	Proteomic studies of B16 lines: Involvement of Annexin A1 in melanoma dissemination 2008 ·Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics ·Fabien Rondepierre,Bernadette Bouchon,Janine Papon,Mathilde Bonnet,(unknown),Nicole Moins,J. Maublant,J. C. Madelmont,M. D’Incan,Françoise Degoul	40
4	Development of a high-performance liquid chromatographic method for the determination of a new potent radioiodinated melanoma imaging and therapeutic agent 2008 ·Journal of Chromatography B ·Delphine Denoyer,P. Labarre,(unknown),Elisabeth Miot‐Noirault,Marie‐Josèphe Galmier,J. C. Madelmont,Jean‐Michel Chezal,Nicole Moins	13
5	A New O6-Alkylguanine-DNA Alkyltransferase Inhibitor Associated with a Nitrosourea (Cystemustine) Validates a Strategy of Melanoma-Targeted Therapy in Murine B16 and Human-Resistant M4Beu Melanoma Xenograft Models 2008 ·Journal of Pharmacology and Experimental Therapeutics ·Maryse Rapp,J. C. Maurizis,Janine Papon,P. Labarre,Ting‐Di Wu,Alain Croisy,Jean‐Luc Guerquin‐Kern,J. C. Madelmont,Emmanuelle Mounetou	7
6	N-(4-iodophenyl)-N′-(2-chloroethyl)urea as a microtubule disrupter: in vitro and in vivo profiling of antitumoral activity on CT-26 murine colon carcinoma cell line cultured and grafted to mice 2007 ·British Journal of Cancer ·(unknown),Françoise Degoul,Yves Communal,Emmanuelle Mounetou,Bernadette Bouchon,(unknown),J. C. Madelmont,Elisabeth Miot-Noirault	13
7	Bystander effects are induced by CENU treatment and associated with altered protein secretory activity of treated tumor cells A relay for chemotherapy? 2006 ·International Journal of Cancer ·Aïcha Demidem,Daniel Morvan,J. C. Madelmont	35
8	Liver protein synthesis stays elevated after chemotherapy in tumour-bearing mice 2005 ·Cancer Letters ·(unknown),(unknown),Alessandra Knowles,S. Evelyn Stewart,J. C. Madelmont,Didier Attaix	5
9	Methionine dependency and cancer treatment 2003 ·Cancer Treatment Reviews ·Eric Cellarier,Xavier Durando,Marie‐Paule Vasson,M.‐C. Farges,(unknown),J. C. Maurizis,J. C. Madelmont,P. Chollet	167
10	Quantitative HRMAS proton total correlation spectroscopy applied to cultured melanoma cells treated by chloroethyl nitrosourea: Demonstration of phospholipid metabolism alterations 2003 ·Magnetic Resonance in Medicine ·Daniel Morvan,Aïcha Demidem,Janine Papon,J. C. Madelmont	44
11	Melanin affinity of N-(2-diethylaminoethyl)-4-iodobenzamide, an effective melanoma imaging agent 2002 ·Melanoma Research ·P. Labarre,Janine Papon,Marie‐France Moreau,Nicole Moins,(unknown),A. Veyre,J. C. Madelmont	33
12	Pharmacokinetic study of cystemustine, administered on a weekly schedule in cancer patients 2002 ·Annals of Oncology ·Eric Cellarier,C. Terret,P. Labarre,(unknown),H. Curé,(unknown),J. C. Maurizis,J. C. Madelmont,P. Chollet,P. Armand	8
13	Establishment of IPC 227 cells as human xenografts in rabbits: a model of uveal melanoma 2000 ·Melanoma Research ·(unknown),J. Michelot,(unknown),Janine Papon,(unknown),Nicole Moins,Daniel Morvan,J. C. Madelmont	13
14	Melanoma-cell toxicity of cystemustine combined with O6-benzyl-N2-acetylguanosine 1998 ·Melanoma Research ·(unknown),Christine Rolhion,(unknown),Eric Débiton,Emmanuelle Mounetou,J. C. Madelmont,Françoise Laval	6
15	Tissue distribution and metabolism in rat of an ethynesulphonamide with filaricidal activity 1997 ·Xenobiotica ·(unknown),(unknown),Jean‐Hugues Trouvin,Philippe M. Loiseau,Philippe Gayral,G. Mahuzier,M. Rapp,P. Labarre,(unknown),J. C. Madelmont,J. C. Maurizis,A. Veyre,(unknown)	2
16	Disposition of stiripentol in the pregnant and non-pregnant female rat 1993 ·Xenobiotica ·J. C. Maurizis,M. Rapp,J. C. Madelmont,J. M. Gillardin,F. Lepage,P. Labarre,(unknown),A. Veyre	1
17	Disposition and metabolism of acetylcholinesterase reactivators 2PAM-I, TMB4 and R665 in rats submitted to organophosphate poisoning 1991 ·Xenobiotica ·(unknown),J. C. Maurizis,J. C. Madelmont,C. Nicolas,(unknown),(unknown),P. DEMERSEMAN,H Sentenac-Roumanou,A. Veyre	21
18	Disposition and metabolism of two acetylcholinesterase reactivators, pyrimidoxime and HI6, in rats submitted to organophosphate poisoning 1990 ·Xenobiotica ·(unknown),J. C. Maurizis,C. Nicolas,J. C. Madelmont,(unknown),(unknown),(unknown),P. DEMERSEMAN,H Sentenac-Roumanou,A. Veyre	29
19	Metabolism of a New Radioprotector; S -Acetyl- N -Glycyl Cysteamine. I. Absorption, Distribution and Excretion Metabolites in Mice Bearing Emt6 Tumours 1988 ·Xenobiotica ·J. C. Maurizis,(unknown),J. C. Madelmont,Marie‐France Moreau,(unknown),J.‐L. IMBACH,A. Veyre	4
20	Qualitative and quantitative analysis of a new sulphur-containing nitrosourea in blood by high-performance liquid chromatography 1987 ·Journal of Chromatography B Biomedical Sciences and Applications ·P. Labarre,(unknown),J. C. Madelmont,(unknown),G Mathé,(unknown)	7

About J. C. Madelmont

J. C. Madelmont is a scholar working on Biochemistry, Cancer Research and Pharmaceutical Science, having authored 53 papers that have together received 800 indexed citations. Recurring topics across this work include Amino Acid Enzymes and Metabolism (8 papers), Cancer therapeutics and mechanisms (8 papers) and Cancer, Hypoxia, and Metabolism (6 papers). The work is most often cited by research in Biochemistry (83 citations), Biotechnology (88 citations) and Pharmaceutical Science (56 citations). J. C. Madelmont has collaborated with scholars based in France, Canada and Mali. Frequent co-authors include Janine Papon, Daniel Morvan, Aïcha Demidem, J. C. Maurizis, P. Chollet, Eric Cellarier, Nicole Moins, Marie‐Paule Vasson, M.‐C. Farges and Xavier Durando. Their work appears in journals such as Journal of Medicinal Chemistry, British Journal of Cancer and Journal of Pharmacology and Experimental Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact